Navigation Links
BioLineRx Announces Promising Initial Phase 2 Results of Acute Myeloid Leukemia Treatment
Date:12/16/2013

JERUSALEM, Dec. 16, 2013 /PRNewswire/ -- BioLineRx (NASDAQ: BLRX; TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML). The early results show that BL-8040, as a stand-alone therapy and in combination with high-dose Cytarabine (Ara-C), is safe at all doses tested to date, and triggers substantial mobilization of cancer cells from the bone marrow to the peripheral blood, thereby increasing the vulnerability of the cells to chemotherapy treatment. In addition, signs of robust apoptosis (cell death) of cancer cells were observed following administration of the higher doses tested to date. The study has not yet reached the highest planned doses, suggesting that a strengthening of BL-8040's effects may be observed in future dosing cohorts.

(Logo: http://photos.prnewswire.com/prnh/20130730/630769 )

The Phase 2 trial is a multicenter, open-label study under an IND, and is designed to evaluate the safety and efficacy of repeated escalating doses of BL-8040 in adult patients with relapsed or refractory AML. The primary endpoints of the study are to assess the safety and tolerability of BL-8040. Secondary endpoints include the pharmacokinetic profile of the drug and an efficacy evaluation, indicated by the extent of mobilization of cancer cells from the bone marrow to the peripheral blood, the level of cancer cell death (apoptosis) and clinical responses.

Eight patients have already been enrolled in the study, out of a total expected enrollment of up to 50 patients at eight clinical sites in the U.S. and Isr
'/>"/>

SOURCE BioLineRx
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. BioLineRx Presents Positive Preclinical Results of Acute Myeloid Leukemia Treatment at ASH Conference
2. BioLineRx Announces New Positive Results in Phase 2a trial for Orally Available Inflammatory Bowel Disease Treatment
3. BioLineRx Reports Publication in Peer Review Journal of Positive Phase 1/2 Results in Stem Cell Mobilization for Multiple Myeloma
4. BioLineRx Reports Third Quarter 2013 Financial Results
5. BioLineRx to Report Third Quarter 2013 Results on November 13, 2013
6. BioLineRx to Hold Analyst and Investor Day in New York on November 21, 2013
7. BioLineRx Receives Regulatory Approval to Commence Phase 1/2 Trial for Novel Treatment of Celiac Disease
8. BioLineRx Announces In-Licensing of BL-9020, for Treatment of Type 1 Diabetes
9. BioLineRx Announces Regulatory Submission for Phase 1/2 Trial for Novel Treatment of Celiac Disease
10. BioLineRx Announces Receipt of a Notice of Allowance from USPTO for Patent on Use of BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C
11. BioLineRx To Present At 15th Annual Rodman & Renshaw Global Investment Conference In New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... , Nov. 28, 2014 Alimera Sciences, ... pharmaceutical company that specializes in the research, development ... into a Securities Purchase Agreement with Deerfield Management ... which Alimera will issue shares of preferred stock ... approximately $50.0 million upon the satisfaction of certain ...
(Date:11/28/2014)... HK$,000Six months endedChange %  30 September 201430 September 2013Turnover 546,011 ... Service Income , 384,242 , 339,113 , ... , 41,377 , 49.5 Medical Insurance Administration Service ... 6.4 Medical Devices and Accessories Sales , 94,580 ... , 2,917 , 9,219 , (68.4) ...
(Date:11/27/2014)... Ireland , November 27, 2014 ... Investigational New Drug (IND) Application with the U.S. Food ... in Hovione,s strategy of developing improved drug delivery options ... for minocycline gel, a novel formulation using a new ... one of the most widely prescribed oral antibiotics for ...
Breaking Medicine Technology:Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing 2Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing 3Golden Meditech Announces 2014 / 2015 Interim Results 2Golden Meditech Announces 2014 / 2015 Interim Results 3Golden Meditech Announces 2014 / 2015 Interim Results 4Golden Meditech Announces 2014 / 2015 Interim Results 5Golden Meditech Announces 2014 / 2015 Interim Results 6Golden Meditech Announces 2014 / 2015 Interim Results 7Golden Meditech Announces 2014 / 2015 Interim Results 8Hovione Files its First Investigational New Drug Application With the FDA 2
... Holdings Inc. (OTC Bulletin Board: CGNH ) announced ... and Series 2 Class B common stockholders a "Stockholder Questionnaire," ... accurate share count of the Company,s shares currently held in ... If you have not received the Stockholder ...
... 8, 2011 New Mexico Software, Inc. ... announced today enhancements to its technology staff in response ... technology products that support medical IT services and solutions. ... remote healthcare diagnosis that use telemedicine solutions and run ...
Cached Medicine Technology:CardioGenics Requests Stockholders to Participate in Stockholder Questionnaires 2New Mexico Software Enhances Technology Staff to Support Anticipated Sales Growth 2New Mexico Software Enhances Technology Staff to Support Anticipated Sales Growth 3
(Date:11/28/2014)... On Monday, November 24, 2014, just in ... America Eastern Wisconsin with a check for over $11,500. ... portion of proceeds to Feeding America Eastern Wisconsin. Once ... Ways to Save” with Turbana bananas and Fyffes pineapples. ... $4 and Turbana bananas were 29 cents per pound. ...
(Date:11/28/2014)... Dr. Paul Vitenas, one of the most awarded ... Holiday Event for those in the area that would like to ... & Glow will take place on December 11, 2014, from 6:00 ... heart of Houston at 4208 Richmond Ave. , “We want ... will come and celebrate the season with us on December 11, ...
(Date:11/28/2014)... (HealthDay News) -- Planning on seconds at Thanksgiving Day ... clinically known as gastroesophageal reflux disease (GERD) -- a few ... an ear, nose and throat specialist at Lenox Hill Hospital ... manage GERD on Thanksgiving: Pace yourself. ... small meals throughout the day. It,s also a good idea ...
(Date:11/28/2014)... 2014 Earlier in the year, ... hugely popular, 2014 MTV Video Music Awards broadcasted ... ground-breaking celebrity centered television advertisements directed at 11.9 ... were estimated by Entertainment Weekly and ... spotlight on celebrities photographed by paparazzi smoking. In ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Lice Troopers Lice ... of its in-home head lice service for moms in ... the center of Coral Gables on Pone De-leon Blvd in ... Harbor Islands that service Miami-Dade & Broward. Lice Troopers ... in South Florida which has been treating families for several ...
Breaking Medicine News(10 mins):Health News:Turbana Partners With Sendik's Food Market to Donate $11,500 to Local Hunger-Relief Non-Profit 2Health News:Turbana Partners With Sendik's Food Market to Donate $11,500 to Local Hunger-Relief Non-Profit 3Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 3Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 2Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 3Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 4Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 5Health News:Lice Troopers Lice Removal Service Expands in Miami-Dade 2
... timely reminder of the issues surrounding the binge drinking ... and alcohol, a team lead by Professor Christine Griffin, ... by the Economic and Social Research Council (ESRC) suggests ... on the role of marketing practices in shaping young ...
... Patrick J. McMahon, CPA, was named the Senior Vice ... System. In his new position, McMahon will be part ... Sisters of Charity Health System (SCHS) as it continues ... overall operations of its 20 health, human service and ...
... to more effective ways to control weight , , FRIDAY, Dec. ... activities at suppressing appetite, according to a U.K. study. ... in three types of sessions. In one, they ran for ... hours. In another, they did 90 minutes of weight lifting ...
... DIET Web Site, Features Weight Loss Calculators, Recipes, Customer Rewards Program, ... ... (PRWEB) December 26, 2008 -- Dr. Siegal,s Direct Nutritionals, LLC, the ... DIET® brand weight loss system and hunger-busting diet cookies and diet ...
... would be a real advance since these cells more ... (HealthDay News) -- Researchers say they,ve found a formula ... a mammal, including long-sought rat stem cells. , ... able to mimic human disease in readily produced, genetically ...
... A dentist who owns a successful dental practice and center for ... weight gain during the holiday may contribute to a energy-robbing and ... the neck region, can further complicate breathing while sleeping. , ... ...
Cached Medicine News:Health News:T'is the season to be jolly? 2Health News:Patrick J. McMahon Named Senior Vice President/CFO of Sisters of Charity Health System 2Health News:Patrick J. McMahon Named Senior Vice President/CFO of Sisters of Charity Health System 3Health News:Vigorous Treadmill Workout Curbs Appetite Hormones 2Health News:Dr. Siegal's COOKIE DIET Launches All-New Web Site and Shortens URL to CookieDiet.com 2Health News:Dr. Siegal's COOKIE DIET Launches All-New Web Site and Shortens URL to CookieDiet.com 3Health News:Dr. Siegal's COOKIE DIET Launches All-New Web Site and Shortens URL to CookieDiet.com 4Health News:Scientists May Isolate Stem Cells From Rats, Other Mammals 2Health News:Holiday Weight Gain May Contribute to Sleep Apnea Extra Pounds May Produce Severe Problems for Adults 2
5 inch (12.7 cm), 2 x 5 mm blade....
Nicati foreign body spud....
In reversible handle for removing foreign bodies....
... Focus Night & Day soft contact ... to protect the cornea and to relieve ... or chronic ocular pathologies such as bullous ... corneal dystrophies as well as post-surgical conditions ...
Medicine Products: